We have been extremely busy pushing the DoH to acknowledge the failings of Expert Group Report which has been impacting on our care and treatment since 18 June 2012.
While we are waiting for NHS to return from their holidays to address our concerns, we made contact with the Director of Consumer Affairs and Public Health at the European Commission to urgently press for clarification on issues relating to one specific chemical found in PIP implants octamethylcyclotetrasiloxane (D4) which is classified as TOXIC.
As a result of our concerns the MHRA have found themselves under close scrutiny and we see the MHRA actively modifying documents, advice and information on their website. While we regard aspects of this positively, because additional data is now being made available to women affected by PIP implants, we are not convinced that MHRA is working in best interests of those affected. We suspect they are actively working to conceal their failures.